AWH - Aspira Women's Health, Inc. Consensus Target

The market capitalization trend for Aspira Women's Health (AWH) on the GURU.Markets platform is 0.00. Business success relies on the recognition of diagnostic methods by gynecologists and the expansion of insurance coverage. The implementation of AI systems and Medicare approval for OvaSuite tests are driving value growth. Sales of early cancer detection systems generate current revenue, while significant R&D investments are already priced in.

AWH: Aspira Women's Health Inc. Price Target Chart 07/04/2022 - 04/26/2025

Analytical breakdowns for Vermillion (AWH)

- stock value and consensus price forecast:

Stock Price aspirawh.com|AWH - Consensus Target

- market capitalization statistics:

Market Valuation Vermillion|AWH - Enterprise Value

- book value of equity indicators:

Accounting Value of a Share Aspira Women's Health|AWH - Company Book Value|Market Cap to Net Assets Ratio aspirawh.com|AWH - Company Total Assets

- debt obligations and liquidity statistics:

- earnings and valuation multiples information:

AWH - Company Net Income|Expected Profit Aspira Women's Health|AWH - Price to Earnings Ratio|Projected Price to Earnings Ratio Aspira Women's Health, Inc.|AWH - Price/Earnings to Growth Ratio|Total Company Value to Operating Income Before Depreciation Ratio Vermillion|AWH - Operating profit EBITDA|Net earnings per share for the last four quarters Aspira Women's Health|AWH - Earnings per share for the last twelve months|Year-over-year net earnings per share change for the last twelve months aspirawh.com|AWH - Earnings growth in current year|Earnings growth forecast for next year Aspira Women's Health

General company analysis:AWH aspirawh.com

This indicator represents the weighted average target price of the asset, reflecting the professional community's expectations regarding the business's fair value. By analyzing changes in the consensus valuation of the security, investors assess the stability of cash flows, which for Aspira Women's Health (AWH) is supported by high physician confidence in their precise tests for the early detection of ovarian cancer.

Competitors of Aspira Women's Health